30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

TherapeuticsMD Inc (TXMD)

Track

Stock chart
Ticker: TXMD Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Thompson Tommy G
1 purchase — total 14,031 USD
Buy 23 Dec 2025
Value US$4,809,771.99 | Price 103.55 | Shares 1,816
Buy 14 Apr 2025
Value US$1,196,682.83 | Price 23.58 | Shares 18,748
Buy 14 Apr 2025
Value US$325.58 | Price 1.00 | Shares 325
Buy 10 Apr 2025
Value US$1,000.35 | Price 0.86 | Shares 1,167
Buy 9 Apr 2025
Value US$993.66 | Price 0.87 | Shares 1,136
Buy 22 Aug 2024
Value US$7,099.00 | Price 1.73 | Shares 4,094
Buy 21 Aug 2024
Value US$2,038.56 | Price 1.70 | Shares 1,200
Sale 7 Dec 2023
Value US$10,187.45 | Price 2.24 | Shares 4,550
Sale 6 Dec 2023
Value US$33,496.45 | Price 2.31 | Shares 14,500
Proposed sale 6 Dec 2023
Value US$70,055.00 | Price 2.49 | Shares 28,134
Sale 12 Apr 2023
Value US$4,275.53 | Price 3.65 | Shares 1,170
Sale 27 Jan 2023
Value US$249.41 | Price 5.09 | Shares 49
Sale 26 Jan 2023
Value US$8,371.18 | Price 5.08 | Shares 1,648
Sale 24 Jan 2023
Value US$37.17 | Price 5.31 | Shares 7
Sale 23 Jan 2023
Value US$6,950.47 | Price 5.34 | Shares 1,302
Sale 30 Dec 2022
Value US$38,657,000.00 | Price 1,333.00 | Shares 29,000
Buy 9 Dec 2022
Value US$90,284.25 | Price 6.09 | Shares 14,825
Sale 9 Dec 2022
Value US$2,019.87 | Price 6.31 | Shares 320
Buy 8 Dec 2022
Value US$1,749.00 | Price 5.83 | Shares 300
Buy 7 Dec 2022
Value US$113,889.86 | Price 5.66 | Shares 20,113
Sale 7 Dec 2022
Value US$20,635.21 | Price 5.26 | Shares 3,922
Sale 6 Dec 2022
Value US$2,165.46 | Price 4.92 | Shares 440
Sale 6 Dec 2022
Value US$5,184.98 | Price 4.95 | Shares 1,048
Sale 6 Dec 2022
Value US$4,601.60 | Price 4.92 | Shares 935
Sale 6 Dec 2022
Value US$4,345.25 | Price 4.78 | Shares 910
Buy 28 Oct 2022
Value US$7,000,000.00 | Price 1,000.00 | Shares 7,000
Buy 30 Sep 2022
Value US$7,000,000.00 | Price 1,000.00 | Shares 7,000
Buy 29 Jul 2022
Value US$12,333,150.00 | Price 822.21 | Shares 15,000
Buy 29 Jul 2022
Value US$2,666,800.00 | Price 4.72 | Shares 565,000
Buy 18 Jul 2022
Value US$106,658.64 | Price 6.03 | Shares 17,688
Buy 15 Jul 2022
Value US$360,799.52 | Price 5.56 | Shares 64,892
Sale 30 Nov 2021
Value US$15,946.59 | Price 0.54 | Shares 29,790
Buy 18 Nov 2021
Value US$578,500.00 | Price 0.58 | Shares 1,000,000
Buy 14 May 2021
Value US$5,300.00 | Price 1.06 | Shares 5,000
Sale 11 May 2021
Value US$70,404.88 | Price 1.04 | Shares 67,697
Sale 11 May 2021
Value US$22,455.68 | Price 1.04 | Shares 21,592
Sale 11 May 2021
Value US$46,022.08 | Price 1.04 | Shares 44,252
Sale 11 May 2021
Value US$5,035.68 | Price 1.04 | Shares 4,842
Sale 11 May 2021
Value US$46,022.08 | Price 1.04 | Shares 44,252
Buy 9 Jun 2020
Value US$36,750.00 | Price 1.47 | Shares 25,000
Buy 9 Jun 2020
Value US$29,610.00 | Price 1.41 | Shares 21,000
Buy 9 Jun 2020
Value US$68,875.00 | Price 1.45 | Shares 47,500
Buy 8 Jun 2020
Value US$38,425.00 | Price 1.45 | Shares 26,500
Buy 5 Jun 2020
Value US$23,000.00 | Price 1.15 | Shares 20,000
Buy 5 Jun 2020
Value US$11,600.00 | Price 1.16 | Shares 10,000
Buy 4 Jun 2020
Value US$9,831.00 | Price 1.13 | Shares 8,700
Buy 4 Jun 2020
Value US$57,000.00 | Price 1.14 | Shares 50,000
Planned sale 3 Feb 2020
Value US$676,920.00 | Price 2.26 | Shares 300,000
Buy 25 Oct 2019
Value US$99,000.00 | Price 2.75 | Shares 36,000
Buy 25 Oct 2019
Value US$198,000.00 | Price 2.75 | Shares 72,000
Buy 25 Oct 2019
Value US$198,000.00 | Price 2.75 | Shares 72,000
Buy 25 Oct 2019
Value US$198,000.00 | Price 2.75 | Shares 72,000
Buy 23 Aug 2019
Value US$27,700.00 | Price 2.77 | Shares 10,000
Buy 20 Aug 2019
Value US$95,900.00 | Price 2.74 | Shares 35,000
Buy 16 Aug 2019
Value US$29,300.00 | Price 2.93 | Shares 10,000
Buy 15 Aug 2019
Value US$29,900.00 | Price 2.99 | Shares 10,000
Buy 14 Aug 2019
Value US$69,000.00 | Price 2.76 | Shares 25,000
Buy 12 Aug 2019
Value US$47,400.00 | Price 3.16 | Shares 15,000
Buy 12 Aug 2019
Value US$9,997.92 | Price 3.18 | Shares 3,144
Buy 9 Aug 2019
Value US$15,200.00 | Price 3.04 | Shares 5,000
Buy 9 Aug 2019
Value US$28,700.00 | Price 2.87 | Shares 10,000
Buy 9 Aug 2019
Value US$155,118.80 | Price 2.96 | Shares 52,405
Buy 13 May 2019
Value US$99,870.00 | Price 3.33 | Shares 30,000
Buy 13 May 2019
Value US$8,016.00 | Price 3.34 | Shares 2,400
Sale 27 Feb 2019
Value US$100,920.00 | Price 5.80 | Shares 17,400
Planned sale 20 Dec 2018
Value US$336,891.66 | Price 3.63 | Shares 92,910
Planned sale 19 Dec 2018
Value US$340,216.00 | Price 3.70 | Shares 92,000
Planned sale 18 Dec 2018
Value US$469,634.90 | Price 3.64 | Shares 129,127
Planned sale 17 Dec 2018
Value US$483,750.00 | Price 3.75 | Shares 129,000
Planned sale 13 Dec 2018
Value US$378,577.29 | Price 4.12 | Shares 91,910
Planned sale 12 Dec 2018
Value US$381,960.60 | Price 4.18 | Shares 91,400
Planned sale 7 Dec 2018
Value US$423,568.00 | Price 4.60 | Shares 92,000
Planned sale 6 Dec 2018
Value US$182,800.00 | Price 4.57 | Shares 40,000
Planned sale 6 Dec 2018
Value US$420,624.00 | Price 4.57 | Shares 92,000
Planned sale 6 Dec 2018
Value US$589,530.00 | Price 4.57 | Shares 129,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-29 2025-12-23 B Purchase
2.8
Thompson Tommy G
Non-Executive Director
1,816 -14.9%
103.55
US$4,809,772 		1,816 -14.9% 103.55 US$4,809,772
2025-04-15 2025-04-14 B Purchase
2.9
Walker Marlan D

Chief Executive Officer

Officer
18,748 -37.5%
23.58
US$1,196,683 		18,748 -37.5% 23.58 US$1,196,683
2025-04-15 2025-04-14 B Purchase
2.8
Thompson Tommy G
Non-Executive Director
26,548 -39.3%
363.68
US$2,117,497 		26,548 -39.3% 363.68 US$2,117,497
2025-04-10 2025-04-10 B Purchase
2.9
Walker Marlan D

Chief Executive Officer

Officer
1,167 +1.6%
0.86
US$1,000 		1,167 +1.6% 0.86 US$1,000
2025-04-10 2025-04-09 B Purchase
2.9
Walker Marlan D

Chief Executive Officer

Officer
1,136 +1.6%
0.87
US$994 		1,136 +1.6% 0.87 US$994
2024-08-26 2024-08-22 B Purchase
1.8
Collins Cooper C.
Non-Executive Director
4,094 +8.5%
1.73
US$7,099 		4,094 +8.5% 1.73 US$7,099
2024-08-23 2024-08-21 B Purchase
1.8
Collins Cooper C.
Non-Executive Director
1,200 +2.6%
1.70
US$2,039 		1,200 +2.6% 1.70 US$2,039
2023-12-07 2023-12-07 S Sale
2.9
Walker Marlan D

Chief Executive Officer

Officer
4,550 -6.8%
2.24
US$10,187 		4,550 -6.8% 2.24 US$10,187
2023-12-07 2023-12-06 S Sale
2.9
Walker Marlan D

Chief Executive Officer

Officer
14,500 -17.8%
2.31
US$33,496 		14,500 -17.8% 2.31 US$33,496
2023-12-06 2023-12-06 PrS Proposed sale
2.9
Walker Marlan D

Officer

Officer
28,134
2.49
US$70,055 		28,134 2.49 US$70,055
2023-04-14 2023-04-12 S Sale
2.9
Walker Marlan D

Chief Executive Officer

Officer
1,170 -8.7%
3.65
US$4,276 		1,170 -8.7% 3.65 US$4,276
2023-01-30 2023-01-27 S Sale
4.0
Donegan Michael C

Prin. Fin. and Acctg. Officer

Officer
49 -0.4%
5.09
US$249 		49 -0.4% 5.09 US$249
2023-01-30 2023-01-26 S Sale
4.0
Donegan Michael C

Prin. Fin. and Acctg. Officer

Officer
1,648 -12.2%
5.08
US$8,371 		1,648 -12.2% 5.08 US$8,371
2023-01-25 2023-01-24 S Sale
4.0
Donegan Michael C

Prin. Fin. and Acctg. Officer

Officer
7 -0.1%
5.31
US$37 		7 -0.1% 5.31 US$37
2023-01-25 2023-01-23 S Sale
4.0
Donegan Michael C

Prin. Fin. and Acctg. Officer

Officer
1,302 -14.6%
5.34
US$6,950 		1,302 -14.6% 5.34 US$6,950
2023-01-03 2022-12-30 S Sale
3.6
Rubric Capital Management LP
Large shareholder
29,000 -100.0%
1,333.00
US$38,657,000 		29,000 -100.0% 1,333.00 US$38,657,000
2022-12-12 2022-12-09 B Purchase
3.6
Rubric Capital Management LP
Large shareholder
14,825 +0.9%
6.09
US$90,284 		14,825 +0.9% 6.09 US$90,284
2022-12-09 2022-12-09 S Sale
1.2
Bernick Brian

Co-Chief Executive Officer

Officer
320 -7.6%
6.31
US$2,020 		320 -7.6% 6.31 US$2,020
2022-12-09 2022-12-08 B Purchase
3.6
Rubric Capital Management LP
Large shareholder
300 +0.0%
5.83
US$1,749 		300 +0.0% 5.83 US$1,749
2022-12-09 2022-12-07 B Purchase
3.6
Rubric Capital Management LP
Large shareholder
20,113 +1.2%
5.66
US$113,890 		20,113 +1.2% 5.66 US$113,890
2022-12-08 2022-12-07 S Sale
2.3
Naughton Gail K
Non-Executive Director
3,922 -100.0%
5.26
US$20,635 		3,922 -100.0% 5.26 US$20,635
2022-12-09 2022-12-06 S Sale
2.2
Glickman Mark A

Co-Chief Executive Officer

Officer
440 -25.4%
4.92
US$2,165 		440 -25.4% 4.92 US$2,165
2022-12-09 2022-12-06 S Sale
2.9
Walker Marlan D

General Counsel

Officer
1,048 -13.6%
4.95
US$5,185 		1,048 -13.6% 4.95 US$5,185
2022-12-09 2022-12-06 S Sale
1.2
Bernick Brian

Co-Chief Executive Officer

Officer
935 -18.2%
4.92
US$4,602 		935 -18.2% 4.92 US$4,602
2022-12-09 2022-12-06 S Sale
4.0
Donegan Michael C

Interim CFO/CAO/VP of Finance

Officer
910 -16.7%
4.78
US$4,345 		910 -16.7% 4.78 US$4,345
2022-10-31 2022-10-28 B Purchase
3.6
Rubric Capital Management LP
Large shareholder
7,000 +31.8%
1,000.00
US$7,000,000 		7,000 +31.8% 1,000.00 US$7,000,000
2022-10-03 2022-09-30 B Purchase
3.6
Rubric Capital Management LP
Large shareholder
7,000 +46.7%
1,000.00
US$7,000,000 		7,000 +46.7% 1,000.00 US$7,000,000
2022-08-01 2022-07-29 B Purchase
3.6
Rubric Capital Management LP
Large shareholder
15,000 +inf%
822.21
US$12,333,150 		15,000 +inf% 822.21 US$12,333,150
2022-08-01 2022-07-29 B Purchase
3.6
Rubric Capital Management LP
Large shareholder
565,000 +48.8%
4.72
US$2,666,800 		565,000 +48.8% 4.72 US$2,666,800
2022-07-19 2022-07-18 B Purchase
3.6
Rubric Capital Management LP
Large shareholder
17,688 +1.6%
6.03
US$106,659 		17,688 +1.6% 6.03 US$106,659
2022-07-19 2022-07-15 B Purchase
3.6
Rubric Capital Management LP
Large shareholder
64,892 +6.0%
5.56
US$360,800 		64,892 +6.0% 5.56 US$360,800
2021-12-02 2021-11-30 S Sale
4.0
Donegan Michael C

CAO and VP of Finance

Officer
29,790 -23.1%
0.54
US$15,947 		29,790 -23.1% 0.54 US$15,947
2021-11-22 2021-11-18 B Purchase
1.8
Collins Cooper C.
Non-Executive Director
1,000,000 +80.8%
0.58
US$578,500 		1,000,000 +80.8% 0.58 US$578,500
2021-05-18 2021-05-14 B Purchase
2.8
Thompson Tommy G
Non-Executive Director
5,000 +0.7%
1.06
US$5,300 		5,000 +0.7% 1.06 US$5,300
2021-05-12 2021-05-11 S Sale
1.5
Finizio Robert G

CEO

Executive Director
67,697 -0.4%
1.04
US$70,405 		67,697 -0.4% 1.04 US$70,405
2021-05-12 2021-05-11 S Sale
2.9
Walker Marlan D

General Counsel

Officer
21,592 -42.8%
1.04
US$22,456 		21,592 -42.8% 1.04 US$22,456
2021-05-12 2021-05-11 S Sale
2.2
BORKOWSKI EDWARD

EVP, Operations

Officer
44,252 -42.8%
1.04
US$46,022 		44,252 -42.8% 1.04 US$46,022
2021-05-12 2021-05-11 S Sale
4.0
Donegan Michael C

CAO and VP Finance

Officer
4,842 -25.5%
1.04
US$5,036 		4,842 -25.5% 1.04 US$5,036
2021-05-12 2021-05-11 S Sale
1.1
Milligan John C.K. IV

Secretary/CEO of subsidiary

Officer
44,252 -2.5%
1.04
US$46,022 		44,252 -2.5% 1.04 US$46,022
2020-06-10 2020-06-09 B Purchase
1.5
Finizio Robert G

CEO

Executive Director
25,000 +0.1%
1.47
US$36,750 		25,000 +0.1% 1.47 US$36,750
2020-06-10 2020-06-09 B Purchase
1.8
Collins Cooper C.
Non-Executive Director
47,500 +51.4%
1.45
US$68,875 		47,500 +51.4% 1.45 US$68,875
2020-06-10 2020-06-09 B Purchase
1.5
Finizio Robert G

CEO

Executive Director
21,000 +0.1%
1.41
US$29,610 		21,000 +0.1% 1.41 US$29,610
2020-06-10 2020-06-08 B Purchase
1.8
Collins Cooper C.
Non-Executive Director
26,500 +40.2%
1.45
US$38,425 		26,500 +40.2% 1.45 US$38,425
2020-06-08 2020-06-05 B Purchase
1.5
Finizio Robert G

CEO

Executive Director
20,000 +0.1%
1.15
US$23,000 		20,000 +0.1% 1.15 US$23,000
2020-06-08 2020-06-05 B Purchase
1.5
Finizio Robert G

CEO

Executive Director
10,000 +0.1%
1.16
US$11,600 		10,000 +0.1% 1.16 US$11,600
2020-06-08 2020-06-04 B Purchase
2.8
Thompson Tommy G
Non-Executive Director
8,700 +1.3%
1.13
US$9,831 		8,700 +1.3% 1.13 US$9,831
2020-06-08 2020-06-04 B Purchase
2.3
BISARO PAUL
Non-Executive Director
50,000 +inf%
1.14
US$57,000 		50,000 +inf% 1.14 US$57,000
2020-02-05 2020-02-03 PlS Planned sale
Krassan Mitchell

Chief Strategy Officer
300,000 -100.0%
2.26
US$676,920 		300,000 -100.0% 2.26 US$676,920
2019-10-29 2019-10-25 B Purchase
1.2
Bernick Brian
36,000 +58.1%
2.75
US$99,000 		36,000 +58.1% 2.75 US$99,000
2019-10-29 2019-10-25 B Purchase
1.1
Milligan John C.K. IV

President/Secretary

Executive Director
72,000 +4.9%
2.75
US$198,000 		72,000 +4.9% 2.75 US$198,000
2019-10-29 2019-10-25 B Purchase
1.5
Finizio Robert G

CEO

Executive Director
72,000 +0.4%
2.75
US$198,000 		72,000 +0.4% 2.75 US$198,000
2019-10-29 2019-10-25 B Purchase
1.1
Milligan John C.K. IV

President/Secretary

Executive Director
72,000 +4.9%
2.75
US$198,000 		72,000 +4.9% 2.75 US$198,000
2019-08-26 2019-08-23 B Purchase Russell Angus C. Non-Executive Director
10,000 +12.0%
2.77
US$27,700 		10,000 +12.0% 2.77 US$27,700
2019-08-20 2019-08-20 B Purchase Finizio Robert G

CEO

Executive Director
35,000 +0.2%
2.74
US$95,900 		35,000 +0.2% 2.74 US$95,900
2019-08-19 2019-08-16 B Purchase Milligan John C.K. IV

President/Secretary

Executive Director
10,000 +0.3%
2.93
US$29,300 		10,000 +0.3% 2.93 US$29,300
2019-08-15 2019-08-15 B Purchase Russell Angus C. Non-Executive Director
10,000 +13.6%
2.99
US$29,900 		10,000 +13.6% 2.99 US$29,900
2019-08-15 2019-08-14 B Purchase Russell Angus C. Non-Executive Director
25,000 +51.5%
2.76
US$69,000 		25,000 +51.5% 2.76 US$69,000
2019-08-14 2019-08-12 B Purchase Milligan John C.K. IV

President/Secretary

Executive Director
15,000 +0.4%
3.16
US$47,400 		15,000 +0.4% 3.16 US$47,400
2019-08-14 2019-08-12 B Purchase Barlow Jane F Non-Executive Director
3,144 +inf%
3.18
US$9,998 		3,144 +inf% 3.18 US$9,998
2019-08-13 2019-08-09 B Purchase Thompson Tommy G Non-Executive Director
5,000 +0.7%
3.04
US$15,200 		5,000 +0.7% 3.04 US$15,200
2019-08-13 2019-08-09 B Purchase Bernick Brian Non-Executive Director
10,000 +19.2%
2.87
US$28,700 		10,000 +19.2% 2.87 US$28,700
2019-08-12 2019-08-09 B Purchase Finizio Robert G

CEO

Executive Director
52,405 +0.3%
2.96
US$155,119 		52,405 +0.3% 2.96 US$155,119
2019-05-15 2019-05-13 B Purchase
1.8
Collins Cooper C.
30,000 +83.3%
3.33
US$99,870 		30,000 +83.3% 3.33 US$99,870
2019-05-14 2019-05-13 B Purchase
2.8
Thompson Tommy G
Non-Executive Director
2,400 +0.4%
3.34
US$8,016 		2,400 +0.4% 3.34 US$8,016
2019-03-01 2019-02-27 S Sale
3.3
MUSING JULES A.
Non-Executive Director
17,400 -77.7%
5.80
US$100,920 		17,400 -77.7% 5.80 US$100,920
2018-12-21 2018-12-20 PlS Planned sale Finizio Robert G

CEO

Executive Director
92,910 -0.5%
3.63
US$336,892 		92,910 -0.5% 3.63 US$336,892
2018-12-21 2018-12-19 PlS Planned sale Finizio Robert G

CEO

Executive Director
92,000 -0.5%
3.70
US$340,216 		92,000 -0.5% 3.70 US$340,216
2018-12-19 2018-12-18 PlS Planned sale Milligan John C.K. IV

President/Secretary

Executive Director
129,127 -8.1%
3.64
US$469,635 		129,127 -8.1% 3.64 US$469,635
2018-12-19 2018-12-17 PlS Planned sale Milligan John C.K. IV

President/Secretary

Executive Director
129,000 -8.1%
3.75
US$483,750 		129,000 -8.1% 3.75 US$483,750
2018-12-14 2018-12-13 PlS Planned sale Bernick Brian Non-Executive Director
91,910 -1.4%
4.12
US$378,577 		91,910 -1.4% 4.12 US$378,577
2018-12-14 2018-12-12 PlS Planned sale Bernick Brian Non-Executive Director
91,400 -1.4%
4.18
US$381,961 		91,400 -1.4% 4.18 US$381,961
2018-12-10 2018-12-07 PlS Planned sale Finizio Robert G

CEO

Executive Director
92,000 -0.5%
4.60
US$423,568 		92,000 -0.5% 4.60 US$423,568
2018-12-10 2018-12-06 PlS Planned sale Cartwright Daniel A

CFO

Officer
40,000 -50.0%
4.57
US$182,800 		40,000 -50.0% 4.57 US$182,800
2018-12-10 2018-12-06 PlS Planned sale Finizio Robert G

CEO

Executive Director
92,000 -0.5%
4.57
US$420,624 		92,000 -0.5% 4.57 US$420,624
2018-12-06 2018-12-06 PlS Planned sale Milligan John C.K. IV

President/Secretary

Executive Director
129,000 -8.1%
4.57
US$589,530 		129,000 -8.1% 4.57 US$589,530
Explore more

More insider trading research around TherapeuticsMD Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America